Next Treatments
Back to Eczema

QLM3003

TypeTopical StagePhase 3 Latest updateMay 16, 2025Phase 3 study started

History

Earliest recorded event: Jun 25, 2023. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

  • May 16, 2025Phase 3 trial startedEfficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis ClinicalTrials.gov NCT06880276
  • Sep 30, 2024Phase 2 trial completedA Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis ClinicalTrials.gov NCT06058000
  • Sep 2, 2024Phase 2 main data collectedA Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis ClinicalTrials.gov NCT06058000
  • Nov 13, 2023Phase 2 trial startedA Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis ClinicalTrials.gov NCT06058000
  • Aug 30, 2023Phase 1 trial completedSafety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects ClinicalTrials.gov NCT05932888
  • Aug 5, 2023Phase 1 main data collectedSafety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects ClinicalTrials.gov NCT05932888
  • Jun 25, 2023Phase 1 trial startedSafety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects ClinicalTrials.gov NCT05932888

Sources

Trials